Science Explorer Back to mapMap
Discussion
Researcher · Sichuan University · China

Libo Yan

Libo Yan publishes mostly in Epidemiology, Molecular Biology and Hepatology, on topics such as Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment and Hepatitis C virus research.

ORCID 0009-0004-4716-6697 OpenAlex
World rank
#3,378,747
of 7,710,434 ranked researchers
Rank in China
#530,493
of 978,568
Works
70
Citations
1.4k
Citations per work
19.3
h-index
18
i10-index 30Top 27% in Epidemiology
Libo Yan

What does Libo Yan research?

Libo Yan's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (19%), Immunology and Microbiology (5%).

Everything else: 27 works · 38.6% of their workHealth Sciences: 27 works · 37.9% of their workMedicine: 27 works · 37.9% of their workEpidemiology: 14 works · 20.3% of their workHepatology: 9 works · 12.8% of their workOncology: 3 works · 4.8% of their workLife Sciences: 16 works · 23.5% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 18.7% of their workMolecular Biology: 9 works · 13.4% of their workCell Biology: 4 works · 5.3% of their workImmunology and Microbiology: 3 works · 4.8% of their workImmunology: 3 works · 4.8% of their workTHEIR WORKLibo Yan70works
Life Sciences24%Health Sciences38%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2738.6%
    1. Medicine2737.9%
    1. Biochemistry, Genetics and Molecular Biology1318.7%
    2. Immunology and Microbiology34.8%
  1. 1Epidemiology20% of their works
  2. 2Molecular Biology13% of their works
  3. 3Hepatology13% of their works
  4. 4Cell Biology5% of their works
  5. 5Oncology5% of their works
  6. 6Immunology5% of their works

Research topics

Which keywords describe Libo Yan's research?

The keywords of their largest research topics: Antiviral Therapy, Hepatocellular Carcinoma, Epidemiology, Insulin Resistance, Chronic Hepatitis B, Hepatitis B Virus, Hepatitis C Virus and NAFLD.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Antiviral Therapy352 topics
  2. Hepatocellular Carcinoma352 topics
  3. Epidemiology202 topics
  4. Insulin Resistance202 topics
  5. Chronic Hepatitis B191 topic
  6. Hepatitis B Virus191 topic
  7. Hepatitis C Virus161 topic
  8. NAFLD161 topic
  9. NASH161 topic
  10. Treatment161 topic
  11. Apoptosis92 topics
  12. Oxidative Stress82 topics
  13. Endoplasmic Reticulum51 topic
  14. Stress51 topic
  15. Hepatitis E Virus41 topic
  16. Protein Kinases41 topic
  17. Ras Signaling41 topic
  18. Sphingolipids41 topic
  19. Sphingosine-1-Phosphate41 topic
  20. Zoonotic Transmission41 topic
  21. Aging31 topic
  22. Longevity31 topic

Where does Libo Yan work?

Libo Yan's main affiliation in the publication record is Sichuan University, China.

How many publications and citations does Libo Yan have?

OpenAlex counts 70 works and 1,353 citations for Libo Yan, an h-index of 18, ranking #3,378,747 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Libo Yan

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Libo Yan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.